Juliet Williams, Ph.D.

Juliet Williams, Ph.D., is currently Head of Research at Kymera, where she is responsible for building the portfolio and delivering developmental candidates and INDs for the clinic. She has more than 20 years of drug discovery experience and has contributed to multiple INDs and medicines during her time at Novartis, Sanofi, Millennium and Curis. Prior to Kymera, she was the Head of Oncology Biology and Small Molecule Drug Discovery at Novartis Institutes for Biomedical Research in Cambridge and served in other leadership positions at both Novartis and Sanofi. Williams holds a degree in Natural Sciences (Biochemistry) from the University of Cambridge and a Ph.D. in Developmental Biology from University College London. Additionally, she completed a Wellcome Postdoctoral Fellowship at University College London in Developmental Biology.

Read more about Juliet Williams.

[Due to a scheduling conflict, Jay Bradner, M.D., Ph.D., Amgen, is unable to present the opening keynote address at SLAS2024.]